Analytical Data
-
基因名
NAA38
- Application
-
别名
LSM domain-containing protein 1;Phosphonoformate immuno-associated protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BRA0
-
表达区间
2-173aa
-
分子量
34.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NAA38, or N-acetyltransferase 38, is a member of the N-terminal acetyltransferase family, which plays a crucial role in the post-translational modification of proteins through N-terminal acetylation. This modification is vital for protein stability, cellular localization, and interaction with other biomolecules, thereby influencing various cellular processes. Recent studies suggest that NAA38 may have important implications in various biological functions and diseases, including cancer and neurodegenerative disorders. Understanding the structure and function of NAA38 can provide insights into its biological roles and potential therapeutic targets. The recombinant production of NAA38 not only facilitates detailed biochemical characterization but also allows for the exploration of its enzymatic activity and substrate specificity. This research aims to elucidate the molecular mechanisms by which NAA38 influences protein function and to assess its potential as a biomarker or target for drug development. By leveraging recombinant protein technology, scientists can create a platform for high-throughput screening of inhibitors or modulators of NAA38, which may ultimately lead to novel therapeutic strategies in diseases where acetylation processes are disrupted.
